Tamila V. Martynyuk

Tamila V. Martynyuk


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2022 in Cells
Verified
Journal Article
Open access
PDF file
EAElvin S. Allakhverdiev
Elvin S. Allakhverdiev
VKVenera V. Khabatova
Venera V. Khabatova
BKBekzhan D. Kossalbayev
Bekzhan D. Kossalbayev
EZElena V. Zadneprovskaya
Elena V. Zadneprovskaya
OROleg V. Rodnenkov
Oleg V. Rodnenkov
Suleyman I. AllakhverdievSuleyman I. Allakhverdiev
Suleyman I. Allakhverdiev
Nowadays, there is an interest in biomedical and nanobiotechnological studies, such as studies on carotenoids as antioxidants and studies on molecular markers for cardiovascular, endocrine, and oncological diseases. Moreover, interest in industrial production of microalgal biomass for biofuels and bioproducts has stimulated studies on microalgal physiology and mechanisms of synthesis and accumulation of valuable biomolecules in algal cells. Biomolecules such as neutral lipids and carotenoids are being actively explored by the biotechnology community. Raman spectroscopy (RS) has become an important tool for researchers to understand biological processes at the cellular level in medicine and biotechnology. This review provides a brief analysis of existing studies on the application of RS for investigation of biological, medical, analytical, photosynthetic, and algal research, particularly to understand how the technique can be used for lipids, carotenoids, and cellular research. First, the review article shows the main applications of the modified Raman spectroscopy in medicine and biotechnology. Research works in the field of medicine and biotechnology are analysed in terms of showing the common connections of some studies as caretenoids and lipids. Second, this article summarises some of the recent advances in Raman microspectroscopy applications in areas related to microalgal detection. Strategies based on Raman spectroscopy provide potential for biochemical-composition analysis and imaging of living microalgal cells, in situ and in vivo. Finally, current approaches used in the papers presented show the advantages, perspectives, and other essential specifics of the method applied to plants and other species/objects.

24 October 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
SAS. N. Avdeev
S. N. Avdeev
OBO. L. Barbarash
O. L. Barbarash
ZVZ. S. Valieva
Z. S. Valieva
AVA. V. Volkov
A. V. Volkov
TVT. N. Veselova
T. N. Veselova
NTN. A. Tsareva
N. A. Tsareva
The Russian Society of Cardiology (RSC)With the participation of: the Russian Association of Cardiovascular Surgeons, Eurasian Association of Cardiology (EAC), The Russian Medical Society on Arterial Hypertension (RMSAH), Russian Respiratory Society (RRS), the Association of Anesthesiologists and Intensive Care Specialists, the Russian Society of Radiologists and Radiologists (RSRR), the Association of Rheumatologists of Russia.Endorsed by the Research and Practical Council of the Ministry of Health of the Russian Federation (12.09.2024).

30 March 2021 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
ICI. E. Chazova
I. E. Chazova
TMTamila V. Martynyuk
Tamila V. Martynyuk
ZVZ. S. Valieva
Z. S. Valieva
VAV. A. Azizov
V. A. Azizov
RAR. S. Akchurin
R. S. Akchurin
ОВО. Я. Васильцева
О. Я. Васильцева
DisclaimerThe EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the EAC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EAC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the EAC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the EAC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

11 March 2024 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
ICI. E. Chazova
I. E. Chazova
TMTamila V. Martynyuk
Tamila V. Martynyuk
Anton A. ShmaltsAnton A. Shmalts
Anton A. Shmalts
VGV. V. Gramovich
V. V. Gramovich
NDN. M. Danilov
N. M. Danilov
ICI. E. Chernogrivov
I. E. Chernogrivov
Евразийские рекомендации по диагностике и лечению лёгочной гипертензии (2023)

4 September 2018 in Lung
Verified
Journal Article
Open access
PDF file
Irina Nikolaevna LyapinaIrina Nikolaevna Lyapina
Irina Nikolaevna Lyapina
ABAnna A. Belevskaya
Anna A. Belevskaya
MSMarina A. Saidova
Marina A. Saidova
TMTamila V. Martynyuk
Tamila V. Martynyuk
ICIrina E. Chazova
Irina E. Chazova
To evaluate the influence of riociguat on World Health Organization functional class (WHO FC), 6-min walk distance (6MWD), right heart remodeling, and right ventricular–pulmonary arterial (RV–PA) coupling in patients with idiopathic pulmonary arterial hypertension (IPAH) who are treatment-naïve or who have failed to achieve treatment goals with sildenafil therapy.

15 September 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
ZVZarina S. Valieva
Zarina S. Valieva
TMTamila V. Martynyuk
Tamila V. Martynyuk
SNSergei N. Nakonechnikov
Sergei N. Nakonechnikov
ICIrina E. Chazova
Irina E. Chazova
Aim. To assess demographic and clinical characteristics, to describe of the functional and hemodynamic status, profile of concomitant pathology, data of instrumental examination in chronic thromboembolic pulmonary hypertension (CTEPH) patients; to study the features of specific and supportive therapy according to the data of the Russian national registry. Materials and methods. From 2012 till 2020 a multicenter, prospective study in 15 regional expert centers of the Russian Federation (www.medibase.pro) included 404 newly diagnosed CTEPH patients over the age of 18 years in the Russian registry of patients with pulmonary arterial hypertension and CTEPH (NCT03707561). The diagnosis was established by European and Russian clinical guidelines for the diagnosis and management of pulmonary hypertension. 154 inoperable CTEPH patients an additional analysis of specific and supportive therapy was performed. Results. The study included 404 patients (55.6% women and 44.3% men) at the age of 58.6 [48.6; 69.3] years. Median time from symptom onset to the diagnosis verification waswas 2.4 years (from 0.1 to 2.9 years). 79.1% of patients were in the III and IV functional class (World Health Organization) at the time of diagnosis and in 44.1% with RHF (right heart failure). In assessing the profile of concomitant pathology, it was noted that CTEPH patients were more often with arterial hypertension (39.1%), erosive-ulcerative lesions of the stomach/duodenum (16.1%), atrial fibrillation (13.8%), obesity (13.1%). Distance in 6MWD (6-min walk distance) was 337.2 [250; 422] m, Borg dyspnea index scale 4.1 [3.0; 5.0] points. Hemodynamic parameters according to right heart catheterization were: Mean PAP (pulmonary arterial pressure) (51.114.04) mmHg, CO (cardiac output) (3.50.98) l/min, CI (cardiac index) (2.00.48) l/min/m2, PVR (2008528) dyns/cm5. Conclusion. According to the Russian registry, inoperable CTEPH patients had precapillary PH (pulmonary hypertension) with severe functional status, in combination with frequent concomitant pathology (arterial hypertension, erosive-ulcerative lesions of the stomach/duodenum, atrial fibrillation, obesity, right heart failure). 66% of inoperable CTEPH patients received specific drug therapy.